Student Handbook |
FMST 0414
17 Dec 99
TERMINAL
LEARNING OBJECTIVE:
1.
Given an altitude sickness casualty in a combat environment (day or
night) and the standard Field Medical Service Technician supplies and equipment, manage
altitude sickness, per the references.
(FMST.04.15)
ENABLING
LEARNING OBJECTIVES.
1.
Given a
simulated casualty in a mountainous environment, treat Acute Mountain Sickness(AMS), in accordance with the student handbook. (FMST.04.15a)
2.
Given a
simulated casualty in a mountainous environment, treat, High Altitude Pulmonary Edema (HAPE), in accordance with the student handbook.
(FMST.04.15b)
3.
Given a
simulated casualty in a mountainous environment, treat, High Altitude Cerebral Edema (HACE), in accordance with the student handbook.
(FMST.04.15c)
4.
Without
the aid of references define Acute Mountain Sickness, in accordance with the
student handbook. (FMST.04.15d)
5.
Without
the aid of references and given a list, identify the six signs and symptoms of
6.
Without
the aid of references and given a list, select the correct field treatments for
Acute Mountain Sickness (AMS) in accordance with the student handbook. (FMST.
04.15g)
7.
Without
the aid of references and given a list, select the correct preventive measures
for AMS, in Accordance with the student handbook. (FMST.04.15h)
8.
Without
the aid of references define High Altitude Pulmonary Edema (HAPE), in accordance with the student handbook. (FMST.04.15i)
9.
Without
the aid of references describe the later signs/symptoms of High Altitude
Pulmonary Edema (HAPE), in accordance with the student handbook. (FMST.04.15j)
10.
Without
the aid of references define High Altitude Cerebral Edema (HACE),
11.
Without
the aid of references identify the primary mechanism of High Altitude
Cerebral Edema (HACE), in accordance with the student handbook.
(FMST.04.15l)
A.
ACUTE
MOUNTAIN SICKNESS (AMS)
a.
AMS is
rarely seen below 8,000 feet and will occur in most persons who rapidly ascend
to altitudes greater than 10,000-12,000 feet in elevation.
b.
Aerobic
fitness is not a predictor of getting AMS with exposure to altitude. There is some evidence that prior aerobic fitness leads to increased AMS
incidence most likely due to their body's.
c.
Prior
ascents to altitude without symptoms of AMS is not a guarantee of getting
symptoms with re-ascent. Generally,
there is no correlation between the severity of the illness and increasing altitudes. The incidence in males and females is the same and there is increased incidence in younger
patients.
2. Signs
and Symptoms of Acute Mountain Sickness:
AMS tends to occur within
the first 6-48 hours of reaching altitude and is more
Symptoms include:
1. Headache,
usually throbbing, bitemporal or occipital, typically worse at night, upon awakening, and made worse by Valsalva manuever, or stooping
over. This is the most common and prominent sign.
2. Fatigue
3. Dizziness
4. Anorexia
5. Respiratory
difficulties
a. Dyspnea on exertion (DOE)
b. Cheyne-Stokes breathing
6. Nausea
7.
Vomiting
8. Warm and flushed feeling
of the face
9. Insomnia
10.
Palpatations and vague pains in the posterolateral chest
11.
Decreased capacity for mental work
12. Tinnitus
13. Memory defects
14. Vertigo
15. Ataxia
may occur and it may be progressive.
(The presence of ataxia is ominous and this is a clear indication for
descent).
NOTE:
AMS is commonly misdiagnosed as a viral flu-like illness, exhaustion, or
dehydration.
3. Field
Management:
a. Descend.
The individual should descend 1,000-3,000 feet, at which point
the
patient should have marked relief of symptoms.
b. Overexertion: Avoid
overexertion. Light duty.
c. Fluids
Adequate: Fluid replacement and a light diet.
d. Pain
Relievers: Mild analgesics such as Aspirin, Tylenol, or Motrin to treat the
headache.
e. Hyperventilation.
The victim can also hyperventilate for about one minute
every 10-15 minutes while awake.
f. ALL
PATIENTS WITH AMS SHOULD BE EVALUATED FOR HIGH
ALTITUDE
PULMONARY EDEMA (HAPE).
g. Do
not allow the patient to use any tobacco products.
NOTE:
Dizziness/numbness. Care must be
taken not to hyperventilate to the point of getting dizzy or developing numbness
and tingling fingers, toes, lips.
4. Prevention
Measures:
a. The key and best
approach is:
1. Staged
ascent no higher than 8,000 feet the first day.
2. Spend
the next 24 hours resting.
3. Continue
the ascent at about 1,000 feet altitude gain per day.
4. Avoid
overexertion and tobacco use.
5. Maintain
adequate fluid intake.
6. Use
the “work high/sleep low” concept. This
is called "Graded Ascent"
which is the surest and safest way to prevent AMS.
Day trips to higher
altitude and sleeping at lower altitude allows for a slower ascent but
allows
for the body to adjust to altitude better.
B.
HIGH ALTITUDE PULMONARY EDEMA (HAPE)
1. Definition:
HAPE is a high altitude illness which is characterized by filling of the
lungs with fluid.
a. HAPE
rarely occurs below 8,000 feet and usually occurs above 12,000 feet.
b. Persons
with history of previous attacks of HAPE are likely to have recurrent
episodes with subsequent ascents.
c. HAPE
is more common in high altitude residents who return to sea level then
return to altitude.
d. Episodes
that occur a 8,000 to 10,000 feet usually are related to heavy physical
exertion.
e. The
incidence of HAPE is 13 times greater in the 20 to 29 year age group than
the over 30 year age group.
2. Signs and Symptoms
a. These tend to occur within 24-48 hours after arrival.
Usually the symptoms
of AMS are present before or occur with the symptoms of HAPE.
b.
Early Signs:
1. Dry cough, frequently
occurring at night.
2. Respiratory distress,
made worse by exertion.
3. Mild chest pain, usually
perceived as an ache beneath the sternum.
4. Weakness.
c.
Later Signs:
1.
Cyanosis.
2.
Cough
that produces large amounts of frothy, pink sputum.
3.
Rapid
pulse and respirations.
4.
Audible
gurgling sounds during breathing. When
a stethoscope or
ear is placed on the naked chest, wet-crackling sounds can be heard
as the patient breathes.
5.
Severe
respiratory distress.
3. Field Treatment:
a) The
most important emergency care measure is the
immediate descent to a
lower altitude
since fatalities can occur within 6-12 hours in severe cases.
b) Usually
descent of at least 2,000-3,000 feet below the initial altitude is a
definite treatment and will result in marked improvement.
c) The
patient should be placed in the most comfortable position (usually sitting)
and given high concentration oxygen if available.
d) Remember that the lungs are the target, support
ventilation may be
necessary when indicated.
e) Treat headaches with mild analgesics such as
Tylenol, Motrin, or Aspirin.
f) Remember
HAPE is a MEDICAL EMERGENCY and medevac must be
URGENT.
4. Prevention
Measures. The methods of
prevention are identical to
those
outlined for AMS.
C.
HIGH ALTITUDE CEREBRAL EDEMA (HACE)
1. Definition:
HACE is a high altitude illness that is characterized by swelling of the
brain.
a. HACE can occur as low as 8,000 feet, but typically occurs at more than 12,000 feet.
b. The
incidence of HACE in persons brought rapidly to high altitudes is
approximately 2%.
2. Mechanism of HACE
a. Hypoxia causes cerebral
vasodilatation and an increase in cerebral blood
volume.
3.
Signs and Symptoms:
a. Early signs and symptoms:
1. Headache, which usually is throbbing and may be severe.
2. Nausea, vomiting.
3. Insomnia.
4. Cheyne-Stokes respirations.
b. Later
signs and symptoms:
1. Ataxia (loss of muscle coordination leading to difficulty
maintaining
balance).
2. Confusion, which may progress to stupor, coma and death
without proper
treatment.
3. Paralysis of one or more extremities, which may resemble the
paralysis
seen in stroke.
4. Blindness.
5. Convulsions
c. Many patients develop retinal hemorrhages, which can be seen
with a
opthalmoscope by suitable trained individuals.
The patient is un-aware of the
hemorrhages unless they are present in the parts of the retina
responsible for
sharpest vision (macula).
d. The
most important impediment to early recognition is its insidious onset.
Early signs and symptoms frequently go unrecognized or are ignored by
patients and their companions.
3.
Field Treatment:
a. Treatment
should be immediate since fatalities can occur within a few hours in
severe cases.
b. Once
diagnosed, the patient should be placed in the most comfortable position
possible, descended immediately and should be administered high
concentrations
of oxygen if available.
c. Medevac
to a medical facility ASAP!
4.
Prevention:
a. Prevention
is the same as discussed for AMS and HAPE.
b. There
is no known pharmacological agent for the prevention of HACE.
REFERENCES
(S)
Wilderness
Medicine, Management of Wilderness and Environmental Injuries
Field Medical Service School
Camp Pendleton, California